Genetic deletion or pharmacological inhibition of Mst1 has been shown to attenuate cardiomyocyte apoptosis, improve cardiac function, and reduce infarct size in animal models of myocardial infarction and pressure overload-induced heart failure 48, 49. The gene discussed is MST1; the disease is myocardial infarction.